Page last updated: 2024-09-04
ezetimibe and sulfobromophthalein
ezetimibe has been researched along with sulfobromophthalein in 2 studies
Compound Research Comparison
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (sulfobromophthalein) | Trials (sulfobromophthalein) | Recent Studies (post-2010) (sulfobromophthalein) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 3,209 | 33 | 46 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fromm, MF; Giessmann, T; König, J; Kroemer, HK; Lütjohann, D; Oswald, S; Rimmbach, C; Rosskopf, D; Siegmund, W | 1 |
Duthaler, U; Krähenbühl, S; Malagnino, V; Meyer Zu Schwabedissen, HE; Seibert, I | 1 |
Trials
1 trial(s) available for ezetimibe and sulfobromophthalein
Article | Year |
---|---|
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Topics: Adult; Azetidines; Cells, Cultured; Ezetimibe; Female; Genotype; Humans; Inactivation, Metabolic; Liver; Liver-Specific Organic Anion Transporter 1; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Polymorphism, Single Nucleotide; Sterols; Sulfobromophthalein | 2008 |
Other Studies
1 other study(ies) available for ezetimibe and sulfobromophthalein
Article | Year |
---|---|
OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.
Topics: Biological Transport; Catalytic Domain; Endoplasmic Reticulum, Smooth; Ezetimibe; Glucuronosyltransferase; HeLa Cells; Humans; Intestine, Small; Microsomes, Liver; Organic Anion Transporters; Solute Carrier Proteins; Sulfobromophthalein | 2019 |